<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37608584</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1948-7193</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>17</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>ACS chemical neuroscience</Title><ISOAbbreviation>ACS Chem Neurosci</ISOAbbreviation></Journal><ArticleTitle>Interplay of Metallome and Metabolome in Amyotrophic Lateral Sclerosis: A Study on Cerebrospinal Fluid of Patients Carrying Disease-Related Gene Mutations.</ArticleTitle><Pagination><StartPage>3035</StartPage><EndPage>3046</EndPage><MedlinePgn>3035-3046</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1021/acschemneuro.3c00128</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a lethal progressive neurodegenerative disease, characterized by a loss of function of upper and lower motor neurons. This study aimed to explore probable pathological alterations occurring in individuals with ALS compared to neurologically healthy controls through the analysis of cerebrospinal fluid (CSF), a medium, which directly interacts with brain parenchyma. A total of 7 ALS patients with disease-associated mutations (<i>ATXN2</i>, <i>C9ORF72</i>, <i>FUS</i>, <i>SOD1</i>, and <i>TARDBP</i>) and 13 controls were included in the study. Multiple analytical approaches were employed, including metabolomic and metallomics profiling, as well as genetic screening, using CSF samples obtained from the brain compartment. Data analysis involved the application of multivariate statistical methods. Advanced hyphenated selenium and redox metal (iron, copper, and manganese) speciation techniques and nontargeted Fourier transform ion cyclotron resonance mass spectrometry-based metabolomics were used for data acquisition. Nontargeted metabolomics showed reduced steroids, including sex hormones; additionally, copper and manganese species were found to be the most relevant features for ALS patients. This indicates a potential alteration of sex hormone pathways in the ALS-affected brain, as reflected in the CSF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Solovyev</LastName><ForeName>Nikolay</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-6217-6963</Identifier><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lucio</LastName><ForeName>Marianna</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mandrioli</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Azienda Ospedaliero Universitaria di Modena, 41126 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forcisi</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-1976-7976</Identifier><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanawati</LastName><ForeName>Basem</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Uhl</LastName><ForeName>Jenny</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vinceti</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CREAGEN Research Center of Environmental, Genetic and Nutritional Epidemiology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmitt-Kopplin</LastName><ForeName>Philippe</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michalke</LastName><ForeName>Bernhard</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-6376-2588</Identifier><AffiliationInfo><Affiliation>Analytical BioGeoChemistry Research Unit, Helmholtz Center Munich&#x2500;German Research Center for Environmental Health GmbH, Ingolst&#xe4;dter Landstr. 1, 85764 Neuherberg, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>ACS Chem Neurosci</MedlineTA><NlmUniqueID>101525337</NlmUniqueID><ISSNLinking>1948-7193</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>42Z2K6ZL8P</RegistryNumber><NameOfSubstance UI="D008345">Manganese</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003300" MajorTopicYN="N">Copper</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008345" MajorTopicYN="N">Manganese</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055442" MajorTopicYN="N">Metabolome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">brain steroids</Keyword><Keyword MajorTopicYN="N">disease-related mutations</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">metallomics</Keyword></KeywordList><CoiStatement>The authors declare no
competing financial interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>23</Day><Hour>2</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37608584</ArticleId><ArticleId IdType="pmc">PMC10485893</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.3c00128</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown R. H.; Al-Chalabi A. Amyotrophic Lateral Sclerosis. N. Engl. J. Med. 2017, 377, 162&#x2013;172. 10.1056/nejmra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A.; Logroscino G.; Traynor B. J.; Collins J.; Simeone J. C.; Goldstein L. A.; White L. A. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 2013, 41, 118&#x2013;130. 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J.; Biguzzi S.; Guidi C.; Venturini E.; Sette E.; Terlizzi E.; Ravasio A.; Casmiro M.; Salvi F.; Liguori R.; Rizzi R.; Pietrini V.; Chierici E.; Santangelo M.; Granieri E.; Mussuto V.; Borghi A.; Rinaldi R.; Fini N.; Georgoulopoulou E.; De Pasqua S.; Vinceti M.; Bonvicini F.; Ferro S.; D&#x2019;Alessandro R.; D&#x2019;Alessandro R. Epidemiology of amyotrophic lateral sclerosis in Emilia Romagna Region (Italy): A population based study. Amyotrophic Lateral Scler. Frontotemporal Degener. 2014, 15, 262&#x2013;268. 10.3109/21678421.2013.865752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.865752</ArticleId><ArticleId IdType="pubmed">24863640</ArticleId></ArticleIdList></Reference><Reference><Citation>Violi F.; Solovyev N.; Vinceti M.; Mandrioli J.; Lucio M.; Michalke B. The study of levels from redox-active elements in cerebrospinal fluid of amyotrophic lateral sclerosis patients carrying disease-related gene mutations shows potential copper dyshomeostasis. Metallomics 2020, 12, 668&#x2013;681. 10.1039/d0mt00051e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d0mt00051e</ArticleId><ArticleId IdType="pubmed">32373852</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S.; Walsh C.; Lynch C.; Bede P.; Elamin M.; Kenna K.; McLaughlin R.; Hardiman O. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol., Neurosurg. Psychiatry 2011, 82, 623&#x2013;627. 10.1136/jnnp.2010.224501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.224501</ArticleId><ArticleId IdType="pubmed">21047878</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A.; Mazzini L.; D&#x2019;Alfonso S.; Corrado L.; Canosa A.; Moglia C.; Manera U.; Bersano E.; Brunetti M.; Barberis M.; Veldink J. H.; van den Berg L. H.; Pearce N.; Sproviero W.; McLaughlin R.; Vajda A.; Hardiman O.; Rooney J.; Mora G.; Calvo A.; Al-Chalabi A. The multistep hypothesis of ALS revisited: The role of genetic mutations. Neurology 2018, 91, e635&#x2013;e642. 10.1212/wnl.0000000000005996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.0000000000005996</ArticleId><ArticleId IdType="pmc">PMC6105040</ArticleId><ArticleId IdType="pubmed">30045958</ArticleId></ArticleIdList></Reference><Reference><Citation>Garton F. C.; Trabjerg B. B.; Wray N. R.; Agerbo E. Cardiovascular disease, psychiatric diagnosis and sex differences in the multistep hypothesis of amyotrophic lateral sclerosis. Eur. J. Neurol. 2021, 28, 421&#x2013;429. 10.1111/ene.14554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14554</ArticleId><ArticleId IdType="pubmed">32978838</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufir&#xed;a M.; Gil-Bea F. J.; Fern&#xe1;ndez-Torr&#xf3;n R.; Poza J. J.; Mu&#xf1;oz-Blanco J. L.; Rojas-Garc&#xed;a R.; Riancho J.; L&#xf3;pez de Munain A. ALS: A bucket of genes, environment, metabolism and unknown ingredients. Prog. Neurobiol. 2016, 142, 104&#x2013;129. 10.1016/j.pneurobio.2016.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2016.05.004</ArticleId><ArticleId IdType="pubmed">27236050</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M.; Bottecchi I.; Fan A.; Finkelstein Y.; Mandrioli J. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis?. Rev. Environ. Health 2012, 27, 19&#x2013;41. 10.1515/reveh-2012-0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2012-0002</ArticleId><ArticleId IdType="pubmed">22755265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M. D.; Little J.; Gomes J.; Cashman N. R.; Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 2017, 61, 101&#x2013;130. 10.1016/j.neuro.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M.; Filippini T.; Violi F.; Rothman K. J.; Costanzini S.; Malagoli C.; Wise L. A.; Odone A.; Signorelli C.; Iacuzio L.; Arcolin E.; Mandrioli J.; Fini N.; Patti F.; Lo Fermo S.; Pietrini V.; Teggi S.; Ghermandi G.; Scillieri R.; Ledda C.; Mauceri C.; Sciacca S.; Fiore M.; Ferrante M. Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis. Environ. Health 2017, 16, 91.10.1186/s12940-017-0297-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12940-017-0297-2</ArticleId><ArticleId IdType="pmc">PMC5576246</ArticleId><ArticleId IdType="pubmed">28851431</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M.; Violi F.; Tzatzarakis M.; Mandrioli J.; Malagoli C.; Hatch E. E.; Fini N.; Fasano A.; Rakitskii V. N.; Kalantzi O. I.; Tsatsakis A. Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case-control study. Environ. Res. 2017, 155, 261&#x2013;267. 10.1016/j.envres.2017.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2017.02.025</ArticleId><ArticleId IdType="pubmed">28242563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray E.; Larkin J. R.; Claridge T. D. W.; Talbot K.; Sibson N. R.; Turner M. R. The longitudinal cerebrospinal fluid metabolomic profile of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler. Frontotemporal Degener. 2015, 16, 456&#x2013;463. 10.3109/21678421.2015.1053490.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1053490</ArticleId><ArticleId IdType="pmc">PMC4720042</ArticleId><ArticleId IdType="pubmed">26121274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D.; Veyrat-Durebex C.; Vourc&#x2019;h P.; Andres C. R.; Blasco H.; Corcia P. Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis. Genes 2020, 11, 537.10.3390/genes11050537.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11050537</ArticleId><ArticleId IdType="pmc">PMC7288444</ArticleId><ArticleId IdType="pubmed">32403313</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H.; Patin F.; Madji Hounoum B.; Gordon P. H.; Vourc&#x2019;h P.; Andres C. R.; Corcia P. Metabolomics in amyotrophic lateral sclerosis: how far can it take us?. Eur. J. Neurol. 2016, 23, 447&#x2013;454. 10.1111/ene.12956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12956</ArticleId><ArticleId IdType="pubmed">26822316</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu G.; Kumar A.; Bala L.; Kalita J.; Misra U.; Singh R.; Khetrapal C. Metabolomic analysis of serum by (1) H NMR spectroscopy in amyotrophic lateral sclerosis. Clin. Chim. Acta 2010, 411, 1383&#x2013;1567. 10.1016/j.cca.2010.05.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2010.05.013</ArticleId><ArticleId IdType="pubmed">20096678</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A.; Moritz T.; Marklund S. L.; Antti H.; Andersen P. M. Disease-Related Changes in the Cerebrospinal Fluid Metabolome in Amyotrophic Lateral Sclerosis Detected by GC/TOFMS. PLoS One 2011, 6, e1794710.1371/journal.pone.0017947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0017947</ArticleId><ArticleId IdType="pmc">PMC3070699</ArticleId><ArticleId IdType="pubmed">21483737</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H.; Corcia P.; Pradat P. F.; Bocca C.; Gordon P. H.; Veyrat-Durebex C.; Mavel S.; Nadal-Desbarats L.; Moreau C.; Devos D.; Andres C. R.; Emond P. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry. J. Proteome Res. 2013, 12, 3746&#x2013;3754. 10.1021/pr400376e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr400376e</ArticleId><ArticleId IdType="pubmed">23859630</ArticleId></ArticleIdList></Reference><Reference><Citation>Tracey T. J.; Kirk S. E.; Steyn F. J.; Ngo S. T. The role of lipids in the central nervous system and their pathological implications in amyotrophic lateral sclerosis. Semin. Cell Dev. Biol. 2021, 112, 69&#x2013;81. 10.1016/j.semcdb.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.08.012</ArticleId><ArticleId IdType="pubmed">32962914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Nu&#xf1;ez O.; Jov&#xe9; M.; Torres P.; Sol J.; Fontdevila L.; Romero-Guevara R.; Andr&#xe9;s-Benito P.; Ayala V.; Rossi C.; Boada J.; Povedano M.; Ferrer I.; Pamplona R.; Portero-Otin M. Nuclear lipidome is altered in amyotrophic lateral sclerosis: A pilot study. J. Neurochem. 2021, 158, 482&#x2013;499. 10.1111/jnc.15373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15373</ArticleId><ArticleId IdType="pubmed">33905537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaves-Filho A. B.; Pinto I. F. D.; Dantas L. S.; Xavier A. M.; Inague A.; Faria R. L.; Medeiros M. H. G.; Glezer I.; Yoshinaga M. Y.; Miyamoto S. Alterations in lipid metabolism of spinal cord linked to amyotrophic lateral sclerosis. Sci. Rep. 2019, 9, 11642.10.1038/s41598-019-48059-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48059-7</ArticleId><ArticleId IdType="pmc">PMC6691112</ArticleId><ArticleId IdType="pubmed">31406145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gargiulo-Monachelli G. M.; Sivori M.; Meyer M.; Sica R. E.; De Nicola A. F.; Gonzalez-Deniselle M. C. Circulating gonadal and adrenal steroids in amyotrophic lateral sclerosis: possible markers of susceptibility and outcome. Horm. Metab. Res. 2014, 46, 433&#x2013;439. 10.1055/s-0034-1371891.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0034-1371891</ArticleId><ArticleId IdType="pubmed">24806746</ArticleId></ArticleIdList></Reference><Reference><Citation>Squitti R.; Ghidoni R.; Simonelli I.; Ivanova I. D.; Colabufo N. A.; Zuin M.; Benussi L.; Binetti G.; Cassetta E.; Rongioletti M.; Siotto M. Copper dyshomeostasis in Wilson disease and Alzheimer&#x2019;s disease as shown by serum and urine copper indicators. J. Trace Elem. Med. Biol. 2018, 45, 181&#x2013;188. 10.1016/j.jtemb.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2017.11.005</ArticleId><ArticleId IdType="pubmed">29173477</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri S.; Squitti R.; Haertle T.; Siotto M.; Saboury A. A. Role of Copper in the Onset of Alzheimer&#x2019;s Disease Compared to Other Metals. Front. Aging Neurosci. 2018, 9, 446.10.3389/fnagi.2017.00446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00446</ArticleId><ArticleId IdType="pmc">PMC5810277</ArticleId><ArticleId IdType="pubmed">29472855</ArticleId></ArticleIdList></Reference><Reference><Citation>Cicero C. E.; Mostile G.; Vasta R.; Rapisarda V.; Signorelli S. S.; Ferrante M.; Zappia M.; Nicoletti A. Metals and neurodegenerative diseases. A systematic review. Environ. Res. 2017, 159, 82&#x2013;94. 10.1016/j.envres.2017.07.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2017.07.048</ArticleId><ArticleId IdType="pubmed">28777965</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N.; El-Khatib A. H.; Costas-Rodr&#xed;guez M.; Schwab K.; Griffin E.; Raab A.; Platt B.; Theuring F.; Vogl J.; Vanhaecke F. Cu, Fe, and Zn isotope ratios in murine Alzheimer&#x2019;s disease models suggest specific signatures of amyloidogenesis and tauopathy. J. Biol. Chem. 2021, 296, 100292.10.1016/j.jbc.2021.100292.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.100292</ArticleId><ArticleId IdType="pmc">PMC7949056</ArticleId><ArticleId IdType="pubmed">33453282</ArticleId></ArticleIdList></Reference><Reference><Citation>Linert W.; Kozlowski H.. Metal Ions in Neurological Systems; Springer-Verlag Wien: Vienna, 2012.</Citation></Reference><Reference><Citation>Beltramini M.; Zambenedetti P.; Wittkowski W.; Zatta P. Effects of steroid hormones on the Zn, Cu and MTI/II levels in the mouse brain. Brain Res. 2004, 1013, 134&#x2013;141. 10.1016/j.brainres.2004.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2004.04.010</ArticleId><ArticleId IdType="pubmed">15196976</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A. J.; Krieg J.-C.; Vedder H. Antioxidative and steroid systems in neurological and psychiatric disorders. World J. Biol. Psychiatr. 2005, 6, 26&#x2013;35. 10.1080/15622970510029759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15622970510029759</ArticleId><ArticleId IdType="pubmed">16097403</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J.; Michalke B.; Solovyev N.; Grill P.; Violi F.; Lunetta C.; Conte A.; Sansone V. A.; Sabatelli M.; Vinceti M. Elevated levels of selenium species in cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated gene mutations. Neurodegener. Dis. 2017, 17, 171&#x2013;180. 10.1159/000460253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000460253</ArticleId><ArticleId IdType="pubmed">28478440</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman S. A.; Hardiman O.; Al-Chalabi A.; Chi&#xf3; A.; Savelieff M. G.; Kiernan M. C.; Feldman E. L. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 2022, 21, 465&#x2013;479. 10.1016/s1474-4422(21)00414-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1474-4422(21)00414-2</ArticleId><ArticleId IdType="pmc">PMC9513754</ArticleId><ArticleId IdType="pubmed">35334234</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucio M.; Willkommen D.; Schroeter M.; Sigaroudi A.; Schmitt-Kopplin P.; Michalke B. Integrative Metabolomic and Metallomic Analysis in a Case&#x2013;Control Cohort With Parkinson&#x2019;s Disease. Front. Aging Neurosci. 2019, 11, 331.10.3389/fnagi.2019.00331.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00331</ArticleId><ArticleId IdType="pmc">PMC6908950</ArticleId><ArticleId IdType="pubmed">31866853</ArticleId></ArticleIdList></Reference><Reference><Citation>Willkommen D.; Lucio M.; Moritz F.; Forcisi S.; Kanawati B.; Smirnov K. S.; Schroeter M.; Sigaroudi A.; Schmitt-Kopplin P.; Michalke B. Metabolomic investigations in cerebrospinal fluid of Parkinson&#x2019;s disease. PLoS One 2018, 13, e020875210.1371/journal.pone.0208752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0208752</ArticleId><ArticleId IdType="pmc">PMC6287824</ArticleId><ArticleId IdType="pubmed">30532185</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M.; Solovyev N.; Mandrioli J.; Crespi C. M.; Bonvicini F.; Arcolin E.; Georgoulopoulou E.; Michalke B. Cerebrospinal fluid of newly diagnosed amyotrophic lateral sclerosis patients exhibits abnormal levels of selenium species including elevated selenite. Neurotoxicology 2013, 38, 25&#x2013;32. 10.1016/j.neuro.2013.05.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2013.05.016</ArticleId><ArticleId IdType="pmc">PMC3770807</ArticleId><ArticleId IdType="pubmed">23732511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hare D. J.; Cardoso B. R.; Szymlek-Gay E. A.; Biggs B. A. Neurological effects of iron supplementation in infancy: finding the balance between health and harm in iron-replete infants. Lancet Child Adolesc. Health 2018, 2, 144&#x2013;156. 10.1016/s2352-4642(17)30159-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2352-4642(17)30159-1</ArticleId><ArticleId IdType="pubmed">30169236</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M.; Filippini T.; Mandrioli J.; Violi F.; Bargellini A.; Weuve J.; Fini N.; Grill P.; Michalke B. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: A case-control study. J. Trace Elem. Med. Biol. 2017, 43, 121&#x2013;125. 10.1016/j.jtemb.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5495626</ArticleId><ArticleId IdType="pubmed">28089071</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalke B.; Berthele A. Contribution to selenium speciation in cerebrospinal fluid samples. J. Anal. At. Spectrom. 2011, 26, 165&#x2013;170. 10.1039/c0ja00106f.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c0ja00106f</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalke B.; Willkommen D.; Drobyshev E.; Solovyev N. The importance of speciation analysis in neurodegeneration research. TrAC, Trends Anal. Chem. 2018, 104, 160&#x2013;170. 10.1016/j.trac.2017.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trac.2017.08.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik K.; Zhang Z.; O&#x2019;Reilly &#xc9; J.; Berry J. D.; Clish C. B.; Deik A.; Jeanfavre S.; Kato I.; Kelly R. S.; Kolonel L. N.; Liang L.; Marchand L. L.; McCullough M. L.; Paganoni S.; Pierce K. A.; Schwarzschild M. A.; Shadyab A. H.; Wactawski-Wende J.; Wang D. D.; Wang Y.; Manson J. E.; Ascherio A. Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 2019, 92, e2089&#x2013;e2100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512888</ArticleId><ArticleId IdType="pubmed">30926684</ArticleId></ArticleIdList></Reference><Reference><Citation>Rammouz G.; Lecanu L.; Papadopoulos V. Oxidative Stress-Mediated Brain Dehydroepiandrosterone (DHEA) Formation in Alzheimer&#x2019;s Disease Diagnosis. Front. Endocrinol. 2011, 2, 69.10.3389/fendo.2011.00069.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2011.00069</ArticleId><ArticleId IdType="pmc">PMC3356139</ArticleId><ArticleId IdType="pubmed">22654823</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaignard P.; Liere P.; Th&#xe9;rond P.; Schumacher M.; Slama A.; Guennoun R. Role of Sex Hormones on Brain Mitochondrial Function, with Special Reference to Aging and Neurodegenerative Diseases. Front. Aging Neurosci. 2017, 9, 406.10.3389/fnagi.2017.00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00406</ArticleId><ArticleId IdType="pmc">PMC5725410</ArticleId><ArticleId IdType="pubmed">29270123</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R. C.; Cascio C.; Papadopoulos V. Pathways of Neurosteroid Biosynthesis in Cell Lines from Human Brain. J. Neurochem. 2001, 74, 847&#x2013;859. 10.1046/j.1471-4159.2000.740847.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.740847.x</ArticleId><ArticleId IdType="pubmed">10646538</ArticleId></ArticleIdList></Reference><Reference><Citation>Vedder H.; Anthes N.; Stumm G.; W&#xfc;rz C.; Behl C.; Krieg J. C. Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system. J. Neurochem. 2002, 72, 2531&#x2013;2538. 10.1046/j.1471-4159.1999.0722531.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.0722531.x</ArticleId><ArticleId IdType="pubmed">10349864</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown R. C.; Han Z.; Cascio C.; Papadopoulos V. Oxidative stress-mediated DHEA formation in Alzheimer&#x2019;s disease pathology. Neurobiol. Aging 2003, 24, 57&#x2013;65. 10.1016/s0197-4580(02)00048-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0197-4580(02)00048-9</ArticleId><ArticleId IdType="pubmed">12493551</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D.; Cabantchik Z. I.; Moreau C.; Danel V.; Mahoney-Sanchez L.; Bouchaoui H.; Gouel F.; Rolland A.-S.; Duce J. A.; Devedjian J.-C.; Cassereau J.; Bost M.; Abrial C.; Muller J.; Olivier A.; Le Masson G.; Mathis S.; Djigo D.; Bonabaud S.; Deloire M.; Genestet S.; Menanteau E.; Bourgeois P.; Lefilliatre M.; Viader F.; Abrou M.; Chavanne D.; Bari R.; Guy N.; Arondo S. S.; Rouvet S.; Beauvais K.; Aidan M.; Madec O.; Danel-Brunaud V.; Tard C.; Pleuvret M.; Santraine V.; Moutarde J.; Couratier P.; Lautrette G.; Machat S.; Penoty M.; Villeneuve O.; Labetoulle C.; Catteau J.; Bernard E.; Svahn J.; Neuillet C.; Attarian S.; Grapperon A.-M.; Verschueren A.; Parlanti A.; Heddadji N.; Camu W.; Pittion-Vouyovitch S.; Michaud M.; Chatelain A.; Costa I.; Soriani M.-H.; Declemy A.; Barre C.; Salachas F.; Kolev I.; Antoine J.-C.; Camdessanche J.-P.; Dimier N.; Ferraud K.; Visneux V.; Fleury M.-C.; Cintas P.; Acket B.; Centelles M.; Hermet V.; Corcia P.; Beltran S.; Bakkouche S. Conservative iron chelation for neurodegenerative diseases such as Parkinson&#x2019;s disease and amyotrophic lateral sclerosis. J. Neural. Transm. 2020, 127, 189&#x2013;203. 10.1007/s00702-019-02138-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-019-02138-1</ArticleId><ArticleId IdType="pubmed">31912279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingold I.; Berndt C.; Schmitt S.; Doll S.; Poschmann G.; Buday K.; Roveri A.; Peng X.; Porto Freitas F.; Seibt T.; Mehr L.; Aichler M.; Walch A.; Lamp D.; Jastroch M.; Miyamoto S.; Wurst W.; Ursini F.; Arn&#xe9;r E. S. J.; Fradejas-Villar N.; Schweizer U.; Zischka H.; Friedmann Angeli J. P.; Conrad M. Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. Cell 2018, 172, 409&#x2013;422. 10.1016/j.cell.2017.11.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.11.048</ArticleId><ArticleId IdType="pubmed">29290465</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowman A. B.; Kwakye G. F.; Herrero Hern&#xe1;ndez E.; Aschner M. Role of manganese in neurodegenerative diseases. J. Trace Elem. Med. Biol. 2011, 25, 191&#x2013;203. 10.1016/j.jtemb.2011.08.144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2011.08.144</ArticleId><ArticleId IdType="pmc">PMC3230726</ArticleId><ArticleId IdType="pubmed">21963226</ArticleId></ArticleIdList></Reference><Reference><Citation>Vegeto E.; Villa A.; Della Torre S.; Crippa V.; Rusmini P.; Cristofani R.; Galbiati M.; Maggi A.; Poletti A. The Role of Sex and Sex Hormones in Neurodegenerative Diseases. Endocr. Rev. 2019, 41, 273&#x2013;319. 10.1210/endrev/bnz005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endrev/bnz005</ArticleId><ArticleId IdType="pmc">PMC7156855</ArticleId><ArticleId IdType="pubmed">31544208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.; Kim T. Y.; Cho K. S.; Kim H. N.; Koh J. Y. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2013, 59, 80&#x2013;85. 10.1016/j.nbd.2013.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.07.011</ArticleId><ArticleId IdType="pubmed">23891729</ArticleId></ArticleIdList></Reference><Reference><Citation>Lara A.; Esperante I.; Meyer M.; Liere P.; Di Giorgio N.; Schumacher M.; Guennoun R.; Gargiulo-Monachelli G.; De Nicola A. F.; Gonzalez Deniselle M. C. Neuroprotective Effects of Testosterone in Male Wobbler Mouse, a Model of Amyotrophic Lateral Sclerosis. Mol. Neurobiol. 2021, 58, 2088&#x2013;2106. 10.1007/s12035-020-02209-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02209-5</ArticleId><ArticleId IdType="pubmed">33411236</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemann C. J. H. M.; Visser J. E.; Van Den Bosch L.; Martens G. J. M.; Poelmans G. Integrated molecular landscape of amyotrophic lateral sclerosis provides insights into disease etiology. Brain Pathol. 2018, 28, 203&#x2013;211. 10.1111/bpa.12485.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12485</ArticleId><ArticleId IdType="pmc">PMC8028446</ArticleId><ArticleId IdType="pubmed">28035716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez Deniselle M. C.; Gonz&#xe1;lez S. L.; De Nicola A. F. Cellular basis of steroid neuroprotection in the wobbler mouse, a genetic model of motoneuron disease. Cell. Mol. Neurobiol. 2001, 21, 237&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">11569536</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Broeck L.; Naval-S&#xe1;nchez M.; Adachi Y.; Diaper D.; Dourlen P.; Chapuis J.; Kleinberger G.; Gistelinck M.; Van Broeckhoven C.; Lambert J. C.; Hirth F.; Aerts S.; Callaerts P.; Dermaut B. TDP-43 loss-of-function causes neuronal loss due to defective steroid receptor-mediated gene program switching in Drosophila. Cell Rep. 2013, 3, 160&#x2013;172. 10.1016/j.celrep.2012.12.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.12.014</ArticleId><ArticleId IdType="pubmed">23333275</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi C. I.; Lee Y. D.; Gwag B. J.; Cho S. I.; Kim S. S.; Suh-Kim H. Effects of estrogen on lifespan and motor functions in female hSOD1 G93A transgenic mice. J. Neurol. Sci. 2008, 268, 40&#x2013;47. 10.1016/j.jns.2007.10.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.10.024</ArticleId><ArticleId IdType="pubmed">18054961</ArticleId></ArticleIdList></Reference><Reference><Citation>McLeod V. M.; Chiam M. D. F.; Lau C. L.; Rupasinghe T. W.; Boon W. C.; Turner B. J. Dysregulation of Steroid Hormone Receptors in Motor Neurons and Glia Associates with Disease Progression in ALS Mice. Endocrinology 2020, 161, bqaa113.10.1210/endocr/bqaa113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/endocr/bqaa113</ArticleId><ArticleId IdType="pubmed">32621747</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassa R. M.; Bonafede R.; Boschi F.; Bentivoglio M.; Mariotti R. Effect of physical exercise and anabolic steroid treatment on spinal motoneurons and surrounding glia of wild-type and ALS mice. Brain Res. 2017, 1657, 269&#x2013;278. 10.1016/j.brainres.2016.12.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.12.029</ArticleId><ArticleId IdType="pubmed">28048973</ArticleId></ArticleIdList></Reference><Reference><Citation>Aggarwal T.; Polanco M. J.; Scaramuzzino C.; Rocchi A.; Milioto C.; Emionite L.; Ognio E.; Sambataro F.; Galbiati M.; Poletti A.; Pennuto M. Androgens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosis. Neurobiol. Aging 2014, 35, 1929&#x2013;1938. 10.1016/j.neurobiolaging.2014.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.004</ArticleId><ArticleId IdType="pubmed">24630363</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer M.; Garay L. I.; Kruse M. S.; Lara A.; Gargiulo-Monachelli G.; Schumacher M.; Guennoun R.; Coirini H.; De Nicola A. F.; Gonzalez Deniselle M. C. Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration. J. Steroid Biochem. Mol. Biol. 2017, 174, 201&#x2013;216. 10.1016/j.jsbmb.2017.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2017.09.015</ArticleId><ArticleId IdType="pubmed">28951257</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans M. C.; Gaillard P. J.; de Boer M.; Appeldoorn C.; Dorland R.; Sibson N. R.; Turner M. R.; Anthony D. C.; Stolp H. B. CNS-targeted glucocorticoid reduces pathology in mouse model of amyotrophic lateral sclerosis. Acta Neuropathol. Commun. 2014, 2, 66.10.1186/2051-5960-2-66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2051-5960-2-66</ArticleId><ArticleId IdType="pmc">PMC4229735</ArticleId><ArticleId IdType="pubmed">24923195</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R.; Volanti P.; Vitale F.; Meli F.; Colletti T.; Di Natale A.; La Bella V. Plasma cortisol level in amyotrophic lateral sclerosis. J. Neurol. Sci. 2015, 358, 282&#x2013;286. 10.1016/j.jns.2015.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.09.011</ArticleId><ArticleId IdType="pubmed">26384616</ArticleId></ArticleIdList></Reference><Reference><Citation>Monachelli G. G.; Meyer M.; Rodr&#xed;guez G.; Garay L.; Sica R. E.; De Nicola A. F.; Deniselle M. C. G. Progesterone and cortisol levels in sporadic amyotrophic lateral sclerosis (sALS): correlation with prognostic factors. Horm. Mol. Biol. Clin. Invest. 2011, 6, 167&#x2013;173. 10.1515/hmbci.2011.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hmbci.2011.006</ArticleId><ArticleId IdType="pubmed">25961252</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N.; Drobyshev E.; Blume B.; Michalke B. Selenium at the Neural Barriers: A Review. Front. Neurosci. 2021, 15, 88.10.3389/fnins.2021.630016.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.630016</ArticleId><ArticleId IdType="pmc">PMC7892976</ArticleId><ArticleId IdType="pubmed">33613188</ArticleId></ArticleIdList></Reference><Reference><Citation>Brigelius-Floh&#xe9; R.; Floh&#xe9; L. Regulatory Phenomena in the Glutathione Peroxidase Superfamily. Antioxid. Redox Signaling 2020, 33, 498&#x2013;516. 10.1089/ars.2019.7905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2019.7905</ArticleId><ArticleId IdType="pubmed">31822117</ArticleId></ArticleIdList></Reference><Reference><Citation>May J. M.; Morrow J. D.; Burk R. F. Thioredoxin reductase reduces lipid hydroperoxides and spares alpha-tocopherol. Biochem. Biophys. Res. Commun. 2002, 292, 45&#x2013;49. 10.1006/bbrc.2002.6617.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.2002.6617</ArticleId><ArticleId IdType="pubmed">11890669</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Z.; Li T.; Dong X.; Wang X.; Zhang Z.; Zhao C.; Kang X.; Zheng R.; Li X. Untargeted Metabolomic Profiling of Cuprizone-Induced Demyelination in Mouse Corpus Callosum by UPLC-Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders. Oxid. Med. Cell. Longev. 2021, 2021, 7093844.10.1155/2021/7093844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7093844</ArticleId><ArticleId IdType="pmc">PMC8457991</ArticleId><ArticleId IdType="pubmed">34567412</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y.; Zhai Q.; Wang G.; Liu X.; Zhao J.; Tian F.; Zhang H.; Chen W. Metabolomics analysis reveals heavy metal copper-induced cytotoxicity in HT-29 human colon cancer cells. RSC Adv. 2016, 6, 78445&#x2013;78456. 10.1039/c6ra09320e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6ra09320e</ArticleId></ArticleIdList></Reference><Reference><Citation>Barros A. N. A. B.; Dourado M. E. T.; Pedrosa L. d. F. C.; Leite-Lais L. Association of Copper Status with Lipid Profile and Functional Status in Patients with Amyotrophic Lateral Sclerosis. J. Nutr. Metab. 2018, 2018, 5678698.10.1155/2018/5678698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/5678698</ArticleId><ArticleId IdType="pmc">PMC6079445</ArticleId><ArticleId IdType="pubmed">30116640</ArticleId></ArticleIdList></Reference><Reference><Citation>Kreuzer M.; Stamenkovi&#x107; S.; Chen S.; Andjus P.; Du&#x10d;i&#x107; T. Lipids status and copper in a single astrocyte of the rat model for amyotrophic lateral sclerosis: Correlative synchrotron-based X-ray and infrared imaging. J. Biophotonics 2020, 13, e20200006910.1002/jbio.202000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbio.202000069</ArticleId><ArticleId IdType="pubmed">32463554</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi S.; Finazzi D. Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms. Front. Pharmacol 2014, 5, 99.10.3389/fphar.2014.00099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2014.00099</ArticleId><ArticleId IdType="pmc">PMC4019866</ArticleId><ArticleId IdType="pubmed">24847269</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B. R.; Miller R. G.; Swash M.; Munsat T. L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Scler. Other Mot. Neuron Disord. 2000, 1, 293&#x2013;299. 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai S. L.; Abramzon Y.; Schymick J. C.; Stephan D. A.; Dunckley T.; Dillman A.; Cookson M.; Calvo A.; Battistini S.; Giannini F.; Caponnetto C.; Mancardi G. L.; Spataro R.; Monsurro M. R.; Tedeschi G.; Marinou K.; Sabatelli M.; Conte A.; Mandrioli J.; Sola P.; Salvi F.; Bartolomei I.; Lombardo F.; Mora G.; Restagno G.; Chi&#xf2; A.; Traynor B. J. FUS mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32, 550.e1.10.1016/j.neurobiolaging.2009.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2009.12.020</ArticleId><ArticleId IdType="pmc">PMC2891336</ArticleId><ArticleId IdType="pubmed">20138404</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianferrari G.; Martinelli I.; Zucchi E.; Simonini C.; Fini N.; Vinceti M.; Ferro S.; Gessani A.; Canali E.; Valzania F.; Sette E.; Pugliatti M.; Tugnoli V.; Zinno L.; Stano S.; Santangelo M.; De Pasqua S.; Terlizzi E.; Guidetti D.; Medici D.; Salvi F.; Liguori R.; Vacchiano V.; Casmiro M.; Querzani P.; Curr&#xf2; Dossi M.; Patuelli A.; Morresi S.; Longoni M.; De Massis P.; Rinaldi R.; Borghi A.; Amedei A.; Mandrioli J.; Mandrioli J. Epidemiological, Clinical and Genetic Features of ALS in the Last Decade: A Prospective Population-Based Study in the Emilia Romagna Region of Italy. Biomedicines 2022, 10, 819.10.3390/biomedicines10040819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10040819</ArticleId><ArticleId IdType="pmc">PMC9031824</ArticleId><ArticleId IdType="pubmed">35453569</ArticleId></ArticleIdList></Reference><Reference><Citation>Pensato V.; Tiloca C.; Corrado L.; Bertolin C.; Sardone V.; Del Bo R.; Calini D.; Mandrioli J.; Lauria G.; Mazzini L.; Querin G.; Ceroni M.; Cantello R.; Corti S.; Castellotti B.; Sold&#xe0; G.; Duga S.; Comi G. P.; Cereda C.; Sorar&#xf9; G.; D&#x2019;Alfonso S.; Taroni F.; Shaw C. E.; Landers J. E.; Ticozzi N.; Ratti A.; Gellera C.; Silani V. TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations. J. Neurol. 2015, 262, 1376&#x2013;1378. 10.1007/s00415-015-7739-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7739-y</ArticleId><ArticleId IdType="pmc">PMC6614739</ArticleId><ArticleId IdType="pubmed">25893256</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A.; Mora G.; Sabatelli M.; Caponnetto C.; Lunetta C.; Traynor B. J.; Johnson J. O.; Nalls M. A.; Calvo A.; Moglia C.; Borghero G.; Trojsi F.; La Bella V.; Volanti P.; Simone I.; Salvi F.; Logullo F. O.; Riva N.; Carrera P.; Giannini F.; Mandrioli J.; Tanel R.; Capasso M.; Tremolizzo L.; Battistini S.; Murru M. R.; Origone P.; Zollino M.; Penco S.; Mazzini L.; D&#x2019;Alfonso S.; Restagno G.; Brunetti M.; Barberis M.; Conforti F. L. ATNX2 is not a regulatory gene in Italian amyotrophic lateral sclerosis patients with C9ORF72 GGGGCC expansion. Neurobiol. Aging 2016, 39, 218.e5&#x2013;218.e8. 10.1016/j.neurobiolaging.2015.11.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.027</ArticleId><ArticleId IdType="pmc">PMC4775342</ArticleId><ArticleId IdType="pubmed">26733254</ArticleId></ArticleIdList></Reference><Reference><Citation>Solovyev N.; Vinceti M.; Grill P.; Mandrioli J.; Michalke B. Redox speciation of iron, manganese, and copper in cerebrospinal fluid by strong cation exchange chromatography - sector field inductively coupled plasma mass spectrometry. Anal. Chim. Acta 2017, 973, 25&#x2013;33. 10.1016/j.aca.2017.03.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2017.03.040</ArticleId><ArticleId IdType="pubmed">28502424</ArticleId></ArticleIdList></Reference><Reference><Citation>Forcisi S.; Moritz F.; Lucio M.; Lehmann R.; Stefan N.; Schmitt-Kopplin P. Solutions for Low and High Accuracy Mass Spectrometric Data Matching: A Data-Driven Annotation Strategy in Nontargeted Metabolomics. Anal. Chem. 2015, 87, 8917&#x2013;8924. 10.1021/acs.analchem.5b02049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.5b02049</ArticleId><ArticleId IdType="pubmed">26197019</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X.-T.; Zeng T.. Integrative Analysis of Omics Big Data. In Computational Systems Biology; Methods in Molecular Biology; Huang T., Ed.; Humana Press: New York, NY, USA, 2018; Vol. 1754.</Citation><ArticleIdList><ArticleId IdType="pubmed">29536440</ArticleId></ArticleIdList></Reference><Reference><Citation>Suhre K.; Schmitt-Kopplin P. MassTRIX: mass translator into pathways. Nucleic Acids Res. 2008, 36, W481&#x2013;W484. Web Server issue)10.1093/nar/gkn194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkn194</ArticleId><ArticleId IdType="pmc">PMC2447776</ArticleId><ArticleId IdType="pubmed">18442993</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>